CBP/p300-IN-3 acipran Hydrochloride Smiles: C[C@H]1CC=CC(=O)[C@@H](O)[C@@H](O)C[C@H]2O[C@@H]2C2=CC(=CC(O)=C2C(=O)O1)OC |c:3|

Smiles: C[C@H]1CC=CC(=O)[C@@H](O)[C@@H](O)C[C@H]2O[C@@H]2C2=CC(=CC(O)=C2C(=O)O1)OC |c:3|

21-15)22-23-17/h10-15H

suppress cardiac automaticity

It exhibits a potent activity against FGF/FGFR-mediated signaling in several cancer cell lines and shows an excellent broad spectrum of antitumor activity in several tumor xenograft models representing the major FGF/FGFR relevant tumor histologies including lung

CBP/p300-IN-3 acipran Hydrochloride Smiles: C[C@H]1CC=CC(=O)[C@@H](O)[C@@H](O)C[C@H]2O[C@@H]2C2=CC(=CC(O)=C2C(=O)O1)OC |c:3|CBP p300 IN 3, a p300 CBP histone acetyltransferase inhibitor, Compound 6, is sourced from patent WO 2019049061 A1. Product information CAS Number: 2299226 01 8 Molecular Weight: 431. 53 Formula: C24H29N7O Chemical Name: 2 [6 (diethylamino)pyridin 3 yl] 1 [(1 ethyl 1H pyrazol 3 yl)methyl] N methyl 1H 1,3 benzodiazole 5 carboxamide Smiles: CNC(=O)C1C=C2N=C(C3C=NC(=CC=3)N(CC)CC)N(CC3C=CN(CC)N=3)C2=CC=1 InChiKey: LYVJDLHFTGYNAV UHFFFAOYSA N InChi: